Assertio Therapeutics (Gralise) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Assertio Therapeutics (Gralise) General Information

Description

A formulation of gabapentin indicated for the management of postherpetic neuralgia (PHN), a persistent pain condition caused by nerve damage during shingles, or herpes zoster and viral infections.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • Lake Forest, IL
  • United States
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Acquirer
Corporate Office
  • Lake Forest, IL
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Assertio Therapeutics (Gralise) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Assertio Therapeutics (Gralise)‘s full profile, request access.

Request a free trial

Assertio Therapeutics (Gralise) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Assertio Therapeutics (Gralise)‘s full profile, request access.

Request a free trial

Assertio Therapeutics (Gralise) FAQs

  • Where is Assertio Therapeutics (Gralise) headquartered?

    Assertio Therapeutics (Gralise) is headquartered in Lake Forest, IL.

  • What industry is Assertio Therapeutics (Gralise) in?

    Assertio Therapeutics (Gralise)’s primary industry is Buildings and Property.

  • Is Assertio Therapeutics (Gralise) a private or public company?

    Assertio Therapeutics (Gralise) is a Private company.

  • What is the current valuation of Assertio Therapeutics (Gralise)?

    The current valuation of Assertio Therapeutics (Gralise) is .

  • What is Assertio Therapeutics (Gralise)’s current revenue?

    The current revenue for Assertio Therapeutics (Gralise) is .

  • Who are Assertio Therapeutics (Gralise)’s investors?

    Assertio Holdings has invested in Assertio Therapeutics (Gralise).

  • When was Assertio Therapeutics (Gralise) acquired?

    Assertio Therapeutics (Gralise) was acquired on 13-Jan-2020.

  • Who acquired Assertio Therapeutics (Gralise)?

    Assertio Therapeutics (Gralise) was acquired by Alvogen Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process